{"id":"https://openalex.org/W2185577209","doi":null,"title":"P2Y12 Antagonists: Pharmacology, Efficacy and Patient Considerations","display_name":"P2Y12 Antagonists: Pharmacology, Efficacy and Patient Considerations","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2185577209","mag":"2185577209"},"language":"en","primary_location":{"id":"mag:2185577209","doi":null,"is_oa":false,"landing_page_url":"http://researchpub.org/journal/jcvd/number/vol2-no2/vol2-no2-9.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078169970","display_name":"Raji Shameem","orcid":"https://orcid.org/0000-0002-1391-531X","observed_orcids":["https://orcid.org/0000-0002-1391-531X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raji Shameem","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090212603","display_name":"Muhammad Saad Hamid","orcid":"https://orcid.org/0000-0002-2321-1885","observed_orcids":["https://orcid.org/0000-0002-2321-1885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muhammad Saad Hamid","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2321-1885","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017911610","display_name":"Arvind Randhawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arvind Randhawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019968024","display_name":"Colette Spaccavento","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colette Spaccavento","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5023903984","display_name":"Kirk Garatt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kirk Garatt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p2y12-inhibitors","display_name":"P2Y12 inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/prasugrel","display_name":"prasugrel","score":0.7749999761581421},{"id":"https://openalex.org/keywords/ticagrelor","display_name":"ticagrelor","score":1.0},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":0.9980000257492065},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.8029999732971191},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.9399999976158142},{"id":"https://openalex.org/keywords/atherothrombosis","display_name":"atherothrombosis","score":0.9739999771118164},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.9779999852180481},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.9589999914169312},{"id":"https://openalex.org/keywords/platelet-function","display_name":"platelet function","score":0.6019999980926514},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.5600000023841858},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C2777028646","wikidata":"https://www.wikidata.org/wiki/Q416232","display_name":"Prasugrel","level":4,"score":0.9820770621299744},{"id":"https://openalex.org/C2780890252","wikidata":"https://www.wikidata.org/wiki/Q420542","display_name":"Ticagrelor","level":4,"score":0.967552900314331},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.9490230083465576},{"id":"https://openalex.org/C49059817","wikidata":"https://www.wikidata.org/wiki/Q14916330","display_name":"P2Y12","level":4,"score":0.8893992900848389},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8353937268257141},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.6007358431816101},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4855439364910126},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.47518956661224365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3737918734550476},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3119097054004669},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.11629489064216614}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2185577209","doi":null,"is_oa":false,"landing_page_url":"http://researchpub.org/journal/jcvd/number/vol2-no2/vol2-no2-9.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W144700851","https://openalex.org/W311320695","https://openalex.org/W1553345686","https://openalex.org/W1974238774","https://openalex.org/W1978913815","https://openalex.org/W2000284400","https://openalex.org/W2008951492","https://openalex.org/W2021691830","https://openalex.org/W2022537971","https://openalex.org/W2031081426","https://openalex.org/W2041499413","https://openalex.org/W2055382468","https://openalex.org/W2065589537","https://openalex.org/W2067654607","https://openalex.org/W2071686230","https://openalex.org/W2085260510","https://openalex.org/W2086623284","https://openalex.org/W2106415586","https://openalex.org/W2107797912","https://openalex.org/W2109577952","https://openalex.org/W2118420392","https://openalex.org/W2121178468","https://openalex.org/W2128314375","https://openalex.org/W2131184211","https://openalex.org/W2136149848","https://openalex.org/W2136228924","https://openalex.org/W2138058610","https://openalex.org/W2140255896","https://openalex.org/W2140501627","https://openalex.org/W2144206796","https://openalex.org/W2145323902","https://openalex.org/W2147069547","https://openalex.org/W2150655309","https://openalex.org/W2152376036","https://openalex.org/W2157833432","https://openalex.org/W2157991095","https://openalex.org/W2161367597","https://openalex.org/W2165406450","https://openalex.org/W2169387542"],"related_works":["https://openalex.org/W2467955552","https://openalex.org/W2025158627","https://openalex.org/W4241126139","https://openalex.org/W2165406450","https://openalex.org/W2091521586","https://openalex.org/W6983764213","https://openalex.org/W2187140978","https://openalex.org/W2128350338","https://openalex.org/W2154290887","https://openalex.org/W2045822822"],"abstract_inverted_index":{"\uf020Abstract":[0],"Today":[1],"atherothrombotic":[2],"disease":[3,23],"accounts":[4],"for":[5,58],"up":[6],"to":[7,32,42,80,87,114,175],"40%":[8],"of":[9,16,21,37,90,122,127,139,151,171],"deaths":[10],"in":[11,18,45,120],"Western":[12],"countries.":[13],"The":[14],"role":[15],"platelets":[17],"the":[19,54,88,115,130,149,161,169],"pathogenesis":[20],"atherothrombosis":[22],"is":[24],"well":[25,65],"known.":[26],"Anti-platelet":[27],"drugs":[28],"have":[29,52,101,147],"been":[30,53,112],"shown":[31],"prevent":[33,43],"formation":[34],"and":[35,39,50,73,98,124,144,153,163],"progression":[36],"thrombosis":[38],"are":[40],"used":[41],"complications":[44],"acute":[46],"coronary":[47],"syndrome.":[48],"Aspirin":[49],"clopidogrel":[51,63,110,143],"conventional":[55],"anti-platelet":[56],"therapy":[57],"many":[59],"years.":[60],"Despite":[61],"this,":[62],"has":[64,85,111],"known":[66],"disadvantages":[67],"that":[68,77,100,167],"include":[69],"bleeding,":[70],"delayed":[71],"onset,":[72],"inter-patient":[74],"response":[75],"variability":[76],"may":[78,146],"equate":[79],"negative":[81],"ischemic":[82],"outcomes.":[83],"This":[84],"led":[86],"development":[89],"alternative":[91],"oral":[92,117],"P2Y12":[93,118,173],"antagonists":[94,119],"such":[95],"a":[96],"prasugrel":[97,152],"ticagrelor":[99,154],"undergone":[102],"large":[103],"randomized":[104],"controlled":[105],"trials.":[106],"In":[107,156],"these":[108],"trials,":[109],"compared":[113,141],"newer":[116,131],"terms":[121],"efficacy":[123],"safety.":[125],"Lack":[126],"experience":[128],"with":[129,134,142],"agents,":[132],"combined":[133],"fears":[135],"about":[136],"higher":[137],"rates":[138],"bleeding":[140],"cost,":[145],"slowed":[148],"rate":[150],"adoption.":[155],"this":[157],"article":[158],"we":[159],"review":[160],"pharmacology":[162],"individual":[164],"patient":[165],"considerations":[166],"affect":[168],"decision":[170],"which":[172],"antagonist":[174],"use.":[176]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}